In silico Study of Transmural Dispersion of Repolarization in Non-failing Human Ventricular Myocytes: Contribution to Cardiac Safety Pharmacology

Journal Title: Journal of Pharmaceutical Research International - Year 2015, Vol 7, Issue 2

Abstract

Aims: To investigate the putative usefulness of the in silico determination of transmural dispersion of repolarization (TDR) for early cardiac safety pharmacology. Study Design: Computational simulations. Place and Duration of Study: SCAP Test, Belgium, between September 2014 and March 2015. Methodology: TDR was calculated as the difference between epicardial-midmyocardial action potential duration (APD95) determined in non-failing human ventricular myocytes using the O’Hara-Rudy dynamic algorithm. The role of each ionic current in TDR was investigated by modifying its conductance in the algorithm. The effects of each tested drug on TDR were studied by reducing the IKr, INa and ICaL conductances in the algorithm by a scaling factor which is a function of the IC50 of the drug for IKr, INa and ICaL ionic currents and the maximal effective free therapeutic plasma concentration (EFTPCmax) of the drug. Results: Our simulations showed that TDR was increased by a preferential midmyocardial APD95 prolongation which was induced by net repolarising current reduction via IKr or IKs inhibition and/or ICaL or INaL activation. Drugs’ effects on TDR were in good agreement with their torsade de pointes (TdP) risk according to the CredibleMeds or the Redfern classifications: most torsadogenic tested drugs induced a TDR increase via IKr vs. ICaL and/or INa selective inhibition; while most non-torsadogenic tested drugs induced a TDR decrease via ICaL vs. IKr and/or INa selective inhibition. Conclusion: Based on computer simulations within the human situation, the present study identified the effects of various cardiac ionic currents on TDR amplitude and suggested that in silico study of drugs’ effects on TDR could be informative for early cardiac safety pharmacology.

Authors and Affiliations

Bernard Christophe

Keywords

Related Articles

Amlodipine Abridged Calcium Associated Complex-I Inhibition in 6-OHDA Lesioned Parkinson’s Rat

Aims: The present study was carried out to evaluate Amlodipine, a L-type calcium channel blocker for alleviating or reducing the neurodegeneration in 6-OHDA lesioned rat models. Place and Duration of Study: Department of...

Effects of Wild Artemisia herba-alba Essential Oil on Biofilm-Forming Bacteria

Aims: The aim of the present study was to determine the effects of essential oil of wild Artemisia herba-alba grown in south Jordan on biofilm-forming bacteria. Study Design: Seven bacterial clinical isolates were used i...

Phytochemical Screening, In-vitro Evaluation of Antioxidant and Free Radical Scavenging Activity of Leaves, Stems and Roots of Xanthium strumarium L., (Compositae)

Introduction: Many diseases are associated with oxidative stress caused by free radicals. Current research is directed towards finding naturally occurring antioxidants of plant origin. Xanthium strumarium L. a cocklebur...

Formulation and Characterization of Solid Lipid Nanoparticles Containing Artemether and Lumefantrine for Treatment of P. falciparum

Objective: To investigate sustained release of solid lipid nanoparticles containing Artemether and Lumefantrine against the P. falciparum by the combination of drugs that eventually will decrease the chance of drug resis...

A Novel Acyl-CoA: Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor, GSK2973980A, Inhibits Postprandial Triglycerides and Reduces Body Weight in a Rodent Diet-induced Obesity Model

Background and Aim: Acyl-CoA: diacylglycerol acyltransferase 1 (DGAT1) is a key enzyme catalyzing the final step of triglyceride (TG) synthesis and is implicated in fat absorption and disposition. However, development of...

Download PDF file
  • EP ID EP344313
  • DOI 10.9734/BJPR/2015/17850
  • Views 67
  • Downloads 0

How To Cite

Bernard Christophe (2015). In silico Study of Transmural Dispersion of Repolarization in Non-failing Human Ventricular Myocytes: Contribution to Cardiac Safety Pharmacology. Journal of Pharmaceutical Research International, 7(2), 88-101. https://europub.co.uk/articles/-A-344313